190726-14220

CourtBoard of Veterans' Appeals
DecidedSeptember 30, 2019
Docket190726-14220
StatusUnpublished

This text of 190726-14220 (190726-14220) is published on Counsel Stack Legal Research, covering Board of Veterans' Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
190726-14220, (bva 2019).

Opinion

Citation Nr: AXXXXXXXX Decision Date: 09/30/19 Archive Date: 09/27/19

DOCKET NO. 190726-14220 DATE: September 30, 2019

ORDER

Entitlement to an effective date of April 27, 2011 for the assignment of a 100 percent rating for hypothyroidism is granted.

FINDINGS OF FACT

1. Unappealed rating determinations dated in May and October 2006, April 2008, and March 2009 became final.

2. Liberally construed, the RO received the Veteran’s increased rating claim for his service-connected hypothyroidism on April 27, 2011.

3. Throughout the pendency of the appeal, the Veteran has credibly maintained that his hypothyroidism is manifested by depression, muscular weakness, constipation, sleeplessness, cold intolerance, and fatigue. Medical evidence also attributes his symptoms to his service-connected hypothyroidism.

4. The April 27, 2011, date of receipt of the Veteran’s claim is the earliest date allowable for the grant of a 100 percent rating for hypothyroidism.

CONCLUSION OF LAW

The criteria for the assignment of an effective date of April 27, 2011 for the grant of a 100 percent rating for hypothyroidism have been met. 38 U.S.C. §§ 5110, 5107; 38 C.F.R. §§ 3.102, 3.400, 4.119 Diagnostic Code (DC) 7903 (2016).

REASONS AND BASES FOR FINDINGS AND CONCLUSION

The Veteran served on active duty from November 1962 to December 1964.

This appeal comes before the Board of Veterans’ Appeals (Board) from a July 2019 rating decision by a Department of Veterans Affairs (VA) Regional Office (RO) that granted an increased 100 percent rating for service-connected hypothyroidism, effective January 22, 2019. The Veteran appealed for an earlier effective date.

On August 23, 2017, the President signed into law the Veterans Appeals Improvement and Modernization Act, Pub. L. No. 115-55 (to be codified as amended in 38 U.S.C., 131 Stat. 1105 (2017), also known as the Appeals Modernization Act (AMA). This law creates a new framework for Veterans dissatisfied with VA’s decision on their claim to seek review.

On the VA Form 10182, Decision Review Request Board Appeal (Notice of Disagreement) (NOD), received in July 2019, the Veteran requested a Direct Review by a Veterans Law Judge, declining a Board hearing, and indicating additional evidence would not be submitted in support of the appeal. The Veteran, however, did submit documents with VA Form 10182, which is during a period of time when new evidence is not allowed. The Board may not consider any additional evidence submitted during the period when new evidence is not allowed but notes the documents are not new and were already part of the record prior to the July 2019 rating decision. This decision has been written consistent with the new AMA framework.

The Board notes that the Veteran filed a claim for entitlement to a total disability rating based on individual unemployability (TDIU) in April 2011, which was denied in a July 2011 rating decision. The Veteran filed a timely NOD in May 2012, the RO issued a statement of the case (SOC), but on his timely January 2014 VA Form 9, the Veteran indicated he only appealed the issue of the increased rating evaluation for his service-connected hypothyroidism. The appeal of entitlement to a TDIU was not perfected; therefore, such issue is not before the Board.

Entitlement to an effective date earlier than January 22, 2019 for the grant of a 100 percent rating for hypothyroidism.

In this case, the Veteran contends that an earlier effective date prior to January 22, 2019 should be granted for the award of an increased 100 percent rating for service-connected hypothyroidism. Specifically, he contends that an effective date of March 2009 should be assigned for a 100 percent rating. See his July 2019 NOD.

For effective date claims, in general, unless specifically provided otherwise, the effective date of an evaluation and award of compensation based on an original claim, a claim reopened after final adjudication, or a claim for increase will be the date of receipt of the claim or the date entitlement arose, whichever is later. 38 U.S.C. § 5110(a); 38 C.F.R. § 3.400. The effective date of an award of disability compensation shall be the day following the Veteran’s discharge or release if application therefor is received within one year from such date of discharge or release. 38 U.S.C. § 5110(b)(1).

The effective date for an award of increased compensation shall be the earliest date as of which it is ascertainable that an increase in disability had occurred, provided a claim is received within one year from such date; otherwise, the effective date for an increased rating will be the date of receipt of the claim, or the date entitlement arose, whichever is later. 38 U.S.C. § 5110(a), (b)(3); 38 C.F.R. § 3.400(o).

The Veteran’s hypothyroidism has been rated under 38 C.F.R. § 4.119, DC 7903. This DC was revised effective December 10, 2017. 82 Fed. Reg. 50802 -50806 (November 2, 2017). Because this revision occurred during the pendency of the Veteran’s claim, whichever version is most favorable to him must be applied. However, the new version can only be applied as of its effective date. 38 U.S.C. § 5110(g); 38 C.F.R. § 3.114; VAOPGCPREC 3-2000, 7-2003; Kuzma v. Principi, 341 F.3d 1327, 1328-1329 (Fed. Cir. 2003).

Under the old version of DC 7903, a 10 percent rating is assigned for fatigability or when continuous medication is required for control. A 30 percent rating requires fatigability, constipation, and mental sluggishness. A 60 percent rating requires muscular weakness, mental disturbance, and weight gain. The maximum 100 percent rating is reserved for cold intolerance, muscular weakness, cardiovascular involvement, mental disturbance (dementia, slowing of thought, depression), bradycardia (less than 60 beats per minute), and sleepiness. 38 C.F.R. § 4.119, DC 7903 (2016).

Under the new version of DC 7903, a 30 percent rating is assigned without myxedema. Note 2 following this section in the DC indicates that this rating is to continue for 6 months after initial diagnosis. Thereafter, residuals of disease or medical treatment are to be rated under the most appropriate DC(s) within the appropriate body system. 38 C.F.R. § 4.119, DC 7903 (2018).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mittleider v. West
11 Vet. App. 181 (Veterans Claims, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
190726-14220, Counsel Stack Legal Research, https://law.counselstack.com/opinion/190726-14220-bva-2019.